Responses
Clinical/translational cancer immunotherapy
Original research
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.